Frantz EyeCare reports 98% of Light Adjustable Lens patients achieved refractive accuracy within ±0.50 D of target, exceeding published national cataract surgery benchmarks.
|Articles|December 15, 2004
Insight Equity buys Vision-Ease Lens, takes on name
Ramsey, MN-BMC Industries Inc. has sold most of the assets of its Vision-Ease Lens business to Insight Equity A.P. X, LP, a Texas-based limited partnership.
Advertisement
Ramsey, MN-BMC Industries Inc. has sold most of the assets of its Vision-Ease Lens business to Insight Equity A.P. X, LP, a Texas-based limited partnership.
BMC had agreed to sell parts of the Vision-Ease Lens business as part of its bankruptcy proceedings in the U.S. Bankruptcy Court for the District of Minnesota.
The court authorized the sale to Insight Equity in August. The business is now operating as Vision-Ease Lens.
Advertisement
Related to this article
In this Q&A, Ping Moore, OD, covers emerging dry eye therapies, from selenium sulfide to next-gen cyclosporine, and how subtype-guided care shapes treatment choices.
Ophthalmology is projected to face one of the steepest physician shortages of any subspecialty by 2038.
Two investigational pipeline therapies take aim at the root causes of dry eye disease
Dry eye care pivots to root-cause diagnosis and personalized biologics/devices,
Cataract surgery becomes refractive: learn how IOL choices and preop counseling across distance, intermediate and near turn 20/20 into 20/happy.
Findings from the third annual State of Dry Eye survey link symptom management to quality of life gains, including lower anxiety and improved self-confidence.
June brings FDA clearance for Lumvoa, key retina and glaucoma trials, device deals, and hard truths on AI performance in eye care.
Advertisement
Advertisement